examinations. Serum CA-125 level was detected as 561 U/ mL whilst the other tumour markers were within normal limits including HE4. A peritoneal biopsy was taken and reported necrotizing granulomatous inflammation with caseifications (tuberculosis).
A correct preoperative diagnosis of female peritoneal tuberculosis is usually not possible through clinical findings and laboratory tests. Family and past history, physical examination, routine chest X-ray, ultrasonography and computer tomography (CT) evaluation may not be specific enough for the diagnosis of peritoneal tuberculosis (1) . Laboratory studies to diagnose peritoneal tuberculosis such as isolated mycobacteria, an ascitic adenosinedeaminase (ADA) test and a tuberculin skin test are usually ineffective for diagnosing peritoneal tuberculosis. Patients who present with a pelvic mass, ascites and increased CA-125 level must be considered as ovarian cancer in the differential diagnosis until proven otherwise. Suspicion about peritoneal tuberculosis is a must to conclude diagnosis without any laparotomy or laparoscopy, which emphasizes the importance of and need for new markers. Serum CA-125 level can increase both in benign and malign diseases (4). HE4, which has been proven to be a reliable marker specific to ovaries and epididymis, is not influenced by peritoneal diseases. The employment of HE4 tumour markers not only increases the sensitivity and specificity of the diagnosis of ovarian tumours but also differentiates benign diseases such as peritoneal tuberculosis that may be suspected, especially in young patients with normal levels of HE4.
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